-
Will The Grinch Steal The Santa Claus Rally In 2014?
Thursday, December 11, 2014 - 5:33pm | 789Read More...There are many sayings that are used to describe movements in the financial markets. For example, “Sell in May and go away” and the “January Effect” are two of the most common ones. One that is applicable to the current time period is the “Santa Claus rally....
-
Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines
Thursday, December 11, 2014 - 3:14pm | 400Read More...Ebola-related pharma stocks were mixed Thursday amid plans announced to buy millions of doses of vaccines for the disease once the World Health Organization recommends a drug. The Geneva Global Alliance for Vaccines and Immunization, or Gavi, committed to a plan it said may see up to $300...
-
NewLink Genetics Sinks On Temporary Halt Of Ebola Trial
Thursday, December 11, 2014 - 10:39am | 171Read More...NewLink Genetics Corp (NASDAQ: NLNK) shares fell sharply after a trial of its Ebola vaccine was temporarily halted over safety concerns at a Swiss hospital University of Geneva Hospital halted the Phase I trial "as a precautionary measure" after four patients in the study...
-
Penny Stock Aethlon Medical Gains 28% On Ebola Claim
Monday, November 17, 2014 - 4:41pm | 300Read More...Aethlon Medical, Inc. (OTC: AEMD) extended its gains Monday on news that the penny stock company had tested its blood-purification device on a patient suffering from Ebola in Germany. The San Diego-based company, which has traded as low as $0.10 per share in the past year, recently gained 28...
-
Lakeland Industries Spikes Amid Ebola-Related Sales
Friday, November 14, 2014 - 12:08pm | 135Read More...Lakeland Industries, Inc. (NASDAQ: LAKE) shares surged on news that it “has experienced a significant increase in order activity from demand relating to the Ebola crisis,” according to its press release. Shares spiked over 3 percent Friday morning after the manufacturer of...
-
Have French Scientists Discovered A Cure For HIV?
Thursday, November 13, 2014 - 6:15pm | 659Read More...The current Ebola crisis has stolen headlines from other major diseases. One of them is HIV. On November 4, a group of French scientists brought HIV back to the forefront when they announced they had found the genetic mechanism for a “spontaneous cure” of the dreaded disease....
-
Glaucus Research Profiles Tekmira Pharmaceuticals; Shares Down 2%
Monday, November 10, 2014 - 2:22pm | 227Read More...Shares of Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR) were trading lower on Monday after Glaucus Research highlighted a “Strong Sell” recommendation with a $7 to $10 price target. “Tekmira is hugely overvalued and its share price is poised to collapse,” Glaucus...
-
Goldman Sachs Plays Down Ebola Concerns, Says Cocoa At Greatest Risk
Thursday, November 6, 2014 - 3:01pm | 455Read More...A team of analysts at Goldman Sachs published a report this week examining the potential economic and market implications in the event of an Ebola outbreak. "We find that the economic costs of pandemics can be severe, but that the hit to growth is usually mostly limited to the region where...
-
Ebola Vaccine Contenders
Thursday, October 30, 2014 - 10:44am | 723Read More...In putting together its “Fighting Ebola” motif, online broker Motif Investing analysts identified 11 companies currently working on Ebola drugs and vaccines. As to which of the 11 was a “best bet” to develop an effective vaccine or drug first, Motif CFA and senior...
-
Novavax To Launch Clinical Trial Of Ebola Vaccine
Monday, October 27, 2014 - 11:07am | 138Read More...Novavax, Inc. (NASDAQ: NVAX) will launch a Phase 1 clinical trial of an Ebola vaccine candidate in December, the company said at a conference Sunday in Philadelphia. Novavax gained 5 percent in Monday's session, trading recently at $5.36 per share. Vice President of Vaccine Development...
-
The Market Doesn't Fear Ebola: A Technical Look At Lakeland Industries
Friday, October 24, 2014 - 3:17pm | 724Read More...The fear of the Ebola virus has dominated the headlines of late and brought about heightened volatility. Not only has it brought long overdue volatility to the broad market, but it has also fostered a new sector of stocks: the Ebola sector. These individual stocks fluctuate wildly with each...
-
Stocks Trending Higher In #PreMarket Amid NYC Doctor Testing Positive For Ebola
Friday, October 24, 2014 - 8:21am | 120Read More...Ebola stocks are in play again on Friday following news that a New York City doctor has tested positive for the Ebola virus. Ebola-related stocks trending higher Friday morning: Alpha Pro Tech, Ltd. (NYSE: APT) up 26% Lakeland Industries, Inc. (NASDAQ: LAKE) up 18% Ibio Inc (NYSE...
-
#PreMarket Primer: Friday, October 24: Ebola Fears Weigh On Markets
Friday, October 24, 2014 - 7:47am | 1288Read More...Another case of Ebola in one of America’s largest cities has reignited fears about its spread. Thirty-three-year-old Dr. Craig Spencer contracted the disease while working in West Africa with infected patients through the Doctors Without Borders organization. Spencer was taken into...
-
Markets Boosted From Strong Earnings Releases, Jobless Benefits
Thursday, October 23, 2014 - 5:14pm | 2034Read More...U.S. stocks rose on Thursday after Wednesday's decline on strong earnings reports from Caterpillar and 3M. Also, U.S. data showed a decline in Americans filing for jobless benefits. The bullish sentiment on Wall Street may have been spoiled by fresh reports of a doctor who recently returned...
-
Airline Earnings: Southwest, American Airlines, JetBlue Were All Flying Higher
Thursday, October 23, 2014 - 4:34pm | 506Read More...Several airlines reported earnings on Thursday morning. Investors and traders have been paying particularly close attention to the group in recent weeks as oil prices tumbled while the Ebola scare placed a negative sentiment on the entire sector. Southwest Airlines: Improving Metrics...
